Employees: 35,000
Size IBEX (IBEX) is a United States Industrials company (Miscellaneous Commercial Services) with a market value of $744M, the 2419th largest of 3,085 United States companies the cockpit tracks. Shares closed at $55.77 on 18 Nov 2026.
Performance Over six months the shares gained 78.7%, against -11.9% for the median peer and -2.2% for the United States market (cap-weighted) — 2nd highest of 21 in its peer set.
Growth Revenue grew 15.2% over the last twelve months (peer median +7.5%); the operating margin is 9.1% (peer median 3.9%).
Valuation It trades at 13.5× forward earnings against a peer median of 24.1× (4th cheapest of 15).
Price implies For today's price to make sense, revenue must grow about 1% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is -7 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 14.6 points above its cost of capital (8.5% WACC).
Short interest Short interest is 1.4% of the free float (30 Oct 2026).
Next results Next results expected around 17 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|---|
| Revenue | $668M | $644M | $558M | $509M | $523M |
| Revenue growth | — | +15% | +10% | -3% | — |
| Gross profit | $180M | $171M | $155M | $133M | $130M |
| EBITDA | $81.4M | $76.9M | $65.9M | $60.7M | $75.1M |
| Net income | $49.1M | $46.3M | $36.9M | $33.7M | $31.6M |
| Free cash flow | $32.3M | $31.2M | $27.3M | $27.0M | $22.9M |
| Capital expenditure | $27.3M | $27.8M | $18.4M | $8.86M | $19.0M |
| Total debt | $63.8M | $62.4M | $69.8M | $67.0M | $78.9M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | IBEX | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +21.2% | -9.6% | 2nd highest of 21 |
| 6-month return | +78.7% | -11.9% | 2nd highest of 21 |
| Distance from 52-week high | -3.7% | -38.9% | 2nd highest of 21 |
| Revenue growth (TTM) | +15.2% | +7.5% | 7th highest of 21 |
| Operating margin | 9.1% | 3.9% | 9th highest of 21 |
| Forward P/E | 13.5× | 24.1× | 4th cheapest of 15 |
| Growth the price implies (Req g, 7 yrs) | 1.0% | 4.1% | 3rd least demanding of 11 |
| Growth delivered (Del g) | +7.7% | +8.2% | 6th highest of 11 |
| Hurdle (Req g minus delivered) | -6.7 pp | -4.6 pp | 5th least demanding of 11 |
| ROIC minus cost of capital | +14.6 pp | -3.4 pp | 2nd highest of 19 |
| EV / EBITDA | 9.5× | 8.6× | 3rd most expensive of 6 |
| Net debt / EBITDA | 0.3× | -1.0× | 3rd most indebted of 7 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| IBEX IBEX | United States | $744M | +79% | +15% | 9% | 13.5× | 1.0% | +7.7% |
| Funshine Culture 300860.SZ | China | $739M | 0% | -49% | -35% | 24.2× | 21.5% | -24.6% |
| Shandong Link Science and Technology 001207.SZ | China | $733M | -24% | +7% | 13% | 11.6× | -5.5% | +18.9% |
| Omat Advanced Materials (Guangdong) 688530.SS | China | $757M | -19% | +82% | 9% | n/a | n/a | n/a |
| Cuscal CCL.AX | Australia | $728M | +17% | +19% | 12% | 18.1× | n/a | n/a |
| Funai Soken 9757.T | Japan | $724M | +10% | +5% | 25% | 16.2× | -8.7% | +5.9% |
| Dark Horse Technology 300688.SZ | China | $723M | +12% | -32% | -33% | 576.0× | n/a | n/a |
| Daqian Ecology & Environment 603955.SS | China | $769M | +21% | +217% | -53% | n/a | n/a | n/a |
| Beyondsoft 002649.SZ | China | $769M | -14% | -6% | 2% | 24.1× | 7.0% | +9.2% |
| Shenzhen L&A Design 300949.SZ | China | $715M | +98% | 0% | -28% | n/a | n/a | n/a |
| Aimed Bio 0009K0.KS | South Korea | $778M | -61% | +228% | 34% | n/a | 10.2% | +652.2% |
| Anbang Save-Guard 603373.SS | China | $779M | +6% | -1% | 14% | 38.9× | 5.6% | +5.6% |
| Credit CCP.AX | Australia | $704M | +39% | +7% | 26% | 9.4× | 1.9% | +11.1% |
| PharmaResources (Shanghai) 301230.SZ | China | $695M | -10% | +9% | 0% | 76.5× | 39.0% | +19.5% |
| Shaanxi Lighte Optoelectronics Material 688150.SS | China | $692M | -56% | +14% | 39% | 36.4× | n/a | n/a |
| Beijing Haitian Ruisheng Science Technology 688787.SS | China | $801M | -37% | +34% | 4% | 126.5× | n/a | n/a |
| Aubay AUB.PA | France | $690M | -7% | +27% | 9% | 12.9× | 2.6% | +7.1% |
| BrightView BV | United States | $803M | -29% | +1% | 4% | 19.6× | n/a | n/a |
| Mentari Therapeutics MTRI | United States | $807M | -91% | -83% | -1,239% | n/a | n/a | n/a |
| Zhejiang Zhongxin Fluoride Materials 002915.SZ | China | $683M | -41% | +8% | 2% | 59.0× | n/a | n/a |
| Guizhou Zhenhua E-Chem 688707.SS | China | $681M | -44% | +15% | -17% | n/a | 1.9% | +6.6% |